Now you’re getting it.

Chemotherapy-free ‘cancer vaccine’ moves from mice to human trials at Stanford
A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on...
Now you’re getting it.
Apparently not you … that’s for sure
I’m trying to add depth to your culinary life … why you won’t heed it is your own problem
Doubtful. I’m a derelict douchebag, remember? Of course you don’t, too many hits from the bong
Riiiiiiight. All I’ve ever asked for is proof (data) to support the medical use of Marijuana, but whatever.
anon50325502:
Wrote a whole response, but at the end of the day, you’re just an idiot not worth the time
General response which is only thinking on the surface. You think you answered a question but did not.
I could write 2+2=4 and you wouldn’t understand.
Hope it gave you a boner.
Mmkay…
So did this happen to make my points more valid?
Hope it gave you a boner.
Why you’re thinking of another man’s boner is troubling enough
So did this happen to make my points more valid?
No, being able to perform a basic thing doesn’t help your point.
Fwiw, Zep. This is the exact shit I have to undo when I do the real work
Fuckin shill
And neither does your free-market fantasies.
This makes zero sense, dude.
A shill for who? Medicinal cannabis?
And your free-market fantasies don’t make any sense either
You are making even less sense than usual, which is actually impressive.
Someone’s algorithm is broken.

A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on...
shill for who? Medicinal cannabis?
For pharma companies. By doing such a bad job at stopping them you push people away from your cause.
Like you’re actually so bad at convincing people to support marijuana you might as well be a pharma employee.
A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers
I am so stoked for this. The science is remarkable, and promising. Even if it doesn’t work as well as hoped, it is a potential huge leap forward in our ability to target therapies.